SEC filing · 8-K

Jazz Pharmaceuticals plc: Executive or director change

Jazz Pharmaceuticals announced that Chief Commercial Officer Samantha Pearce intends to retire by June 30, 2027, or upon the appointment of her successor.

Filed October 9, 2026

Neutral news

What happened

On October 6, 2026, Samantha Pearce notified the company of her decision to retire as Executive Vice President and Chief Commercial Officer.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Jazz Pharmaceuticals plc

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.